NSE: HCG · Healthcare · Hospital · Market cap ₹8,766 Cr
· Prev close ₹599.85 · Volume 64.45 K · 52W ₹513–775
Day range for 9 Nov not in the price history yet · 8 Nov ₹590.10–616.00
Last 4 quarters: profit −68.7% on the 4 beforeShare price −6.1% in a month
If profit compounds at 0.0% (CAGR) and the stock ends at 25×, buying at ₹587 returns about −29.5% CAGR over 10 years.
| Growth assumption | Profit growth (CAGR) | Return, 10Y CAGR |
|---|---|---|
| Yours | 0.0% | −29.5% |
| Delivered FY22–26 | −22.9% | −45.7% |
| Net profit, last 4 quarters vs the 4 before | −68.7% | −78.0% |
| Half the delivered pace | −11.5% | −37.6% |
Delivered FY22–26 CAGR −22.9%
This is an exit-multiple calculation, not a discounted cash flow. Inputs: EPS for the 4 quarters Dec 2025 to Sep 2026 ₹0.71, price ₹587.10 (9 Nov 2026, 3:59 pm IST price). Formula: return = (EPS × exit P/E ÷ price)^(1/10) × (1 + growth) − 1. Net profit growth is applied to EPS, so the share count is held constant. A profit fall of 100% or more has no rate and is left blank. Dividends ignored. Arithmetic, not a forecast.